Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (2444)	1/16/2008 5:03:29 PM
From: tuck	Read Replies (1) \| Respond to of 3158

Tender offer run rate of ~10,000 shares a month. So Roche should get their controlling interest in roughly 150 years. >>Roche Extends Tender Offer for Ventana Wednesday January 16, 4:53 pm ET BASEL, Switzerland, Jan. 16 /PRNewswire-FirstCall/ -- Roche (OTCQX: RHHBY; SWX: ROG.VX; RO.S), a world-leading healthcare provider of pharmaceuticals and diagnostics, announced today that it has extended its offer to acquire all of the outstanding common shares of Ventana Medical Systems, Inc. (Nasdaq: VMSI - News) to 5:00 p.m., New York City time on Friday, March 14, 2008. The tender offer was previously scheduled to expire at 5:00 p.m., New York City time, on January 17, 2008. All other terms and conditions of the tender offer remain unchanged. As of the close of business on January 16, 2008, approximately 62,401 shares have been tendered pursuant to the offer. Greenhill & Co. and Citi are acting as financial advisors to Roche and Davis Polk & Wardwell is acting as legal counsel.<< snip Cheers, Tuck